目的探讨冠状动脉内支架再狭窄的机制。
Objective The purpose of this study was to assess the in stent restenotic process by intravascular ultrasound.
现就支架再狭窄的病理及其防治作一综述。
This article reviews the pathology and prevention for in-stent restenosis.
目的探讨冠状动脉内支架再狭窄的相关因素。
Objective To investigate the predictors of in stent restenosis in coronary artery.
对于多支弥漫性支架再狭窄病变，OPCAB可考虑作为首选。
It causes little injuries. OPCAB would be the first choice for treatment of restenosis of multivesselswith diffuse lesions.
统计支架术后再狭窄发生率，分析不同危险因素对支架再狭窄的影响。
The incidence of restenosis were calculated, and the factors of restenosis were analysed by COX regression.
结论：长支架是支架再狭窄的危险因素，闭塞性病变易导致再狭窄发生。
Conclusion: Long stents, the total occlusion lesion may be the risk factors of restenosis.
目的观察中药对冠心病支架术后缺血心肌血管新生以及支架再狭窄的临床疗效。
ObjectiveTo observe the effect of Tongxinfang on coronary collateral formation and stent-restenosis in patients with coronary artery disease after stenting.
术后6个月重复冠状动脉造影，比较两组间的晚期管腔丢失、支架再狭窄率及术后心血管不良事件发生率。
Coronary angiography was performed at the 6th month. The late lumen loss, stent restenosis and major adverse cardiac events were compared in both groups.
目的探讨非体外循环冠状动脉旁路移植术(OPCAB)对老年冠心病患者冠状动脉支架再狭窄的治疗经验。
Objective To explore the experience about off-pump coronary artery bypass grafting (OPCAB) for the treatment of in-stent restenosis in coronary disease.
另一方面，47%的患者出现了再狭窄，而应用裸支架的患者再狭窄发生率据报道是28%，而应用涂层支架的是6%。
On the other hand, restenosis developed in 47% of patients, versus reported rates of 28% for bare metal stents and 6% after drug-eluting stents.
然而，支架也更容易再狭窄从而导致冠状动脉再次闭塞。
However, they are also more likely to lead to restenosis, a recurrence of artery clogging.
结论：肝素化支架在头颈部动脉狭窄的治疗中是安全的，可有效降低血栓和再狭窄的发生。
Conclusion: Heparin coated stents are safe in treatment of neck and cranial stenosis, and may prevent thrombosis and restenosis.
可降解支架为有效的预防、控制及治疗再狭窄的提供了新的方法，成为国内外研究比较活跃的领域。
Biodegradable stent provide an effective method for the prevention, control and treatment to restenosis, which has been a research hot spot.
目的：用置入过大直径冠状动脉内支架的方法，在正常小型猪建立模拟人类冠状动脉再狭窄的实验动物模型。
Objective:To develop an experimental animal model that accurately mimics human coronary restenosis in normal mini swine by implantation of oversized intracoronary stent.
SES置入不受“标签”适应证的限制，靶病变包括支架内再狭窄、静脉搭桥、左主干局部病变、分叉病变和长病变。
The use of SES implantation was not restricted to "on-label" indications, and target lesions included in-stent restenosis, vein graft, left main stem locations, bifurcations, and long lesions.
目的：探讨在不锈钢冠状动脉支架上携带质粒基因，为心血管再狭窄基因治疗的临床应用提供试验依据。
Objective: to investigate stainless steel coronary stent-based plasmid gene delivery system and evaluate its feasibility and effectiveness to gene therapy of cardiovascular restenosis.
目的研究切割球囊成形术（CBA）治疗高龄患者弥漫性冠状动脉（冠脉）支架内再狭窄（ISR）的安全性与疗效。
Objective To evaluate the safety and efficacy of cutting balloon angioplasty (CBA) for diffuse in-stent restenosis (ISR) in elderly patients.
防治静脉移植物再狭窄的方案包括药物治疗、基因治疗和血管外支架。
Therapeutic strategies to prevent vein graft disease include pharmacotherapy, gene therapy and external stenting.
大气道恶性狭窄者采用放置支架，或用电刀、氩气刀或激光灼烧瘤体使之再通的姑息治疗；
In cases with malignant tumors, stenosis or obstructions were relieved by implantation of stents or cautering with electric argoulaser knife.
目的：评估质粒介导下蛋白涂层金属支架局部转染血管内皮生长因子(VEGF)基因对小型猪冠状动脉再狭窄的作用。
Objective: to assess the effects of local vascular endothelial growth factor (VEGF) transfer using protein coated metallic stents on restenosis of coronary arteries in mini swine model.
因此，防止气道支架置入后再狭窄的发生及其处理， 开发疗效更好、副作用更少的新支架是今后研究的热点方向。
To prevent restenosis following stenting, and design stent with better curative effect and less side effects are subjects in future studies.
近来运用包被支架对预防再狭窄取得了令人鼓舞的进展。
The coating stents for the use of preventing restenosis has made considerable headway.
晚期主要有支架移位或再狭窄。
Late complications were displacement and restenosis of the stent.
而置入支架的血管可因一种叫做再狭窄的过程而再次闭塞，这就意味着要二次手术。
The artery in which the stent is placed, however, can become blocked again during a process called restenosis. This re-closure means a repeat surgery.
目的：探讨切割的球囊预扩张对支架内再狭窄的影响。
Objective:To evaluate the effect of cutting balloon pre dilation on stent restenosis.
药物涂层支架的应用显著降低了支架内再狭窄的发生。
In-stent restenosis has been significantly reduced by utilization of drug eluting stents.
目的：探讨临床因素对冠状动脉(冠脉)内支架置入后再狭窄的影响。
Objective: to investigate the relation between coronary stent restenosis and clinic factors.
结论药物涂层支架置入可显著降低冠脉介入术后再狭窄率。
Conclusion Drug-eluting stent implantation can decrease the rate of restenosis significantly in coronary intervention.
本文就目前雷帕霉素涂层支架在临床防治再狭窄研究的最新进展作一综述。
The purpose of this article is to review the relevant preclinical and clinical data in the field of rapamycin eluting stent for the prevention of restenosis.
本文就目前雷帕霉素涂层支架在临床防治再狭窄研究的最新进展作一综述。
The purpose of this article is to review the relevant preclinical and clinical data in the field of rapamycin eluting stent for the prevention of restenosis.
应用推荐